← Eichor
Study identifier: NCT07693621 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intraperitoneal Dexmedetomidine Versus Magnesium as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy

Condition: Dexmedetomidine · Magnesium Sulfate · Laparoscopic Cholecystectomy  ·  Sponsor: Alexandria University

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

Although both dexmedetomidine and magnesium sulphate have been individually evaluated as adjuvants to local anesthetics, direct comparisons between the two agents in intraperitoneal instillation during laparoscopic cholecystectomy remain limited. Understanding their relative efficacy and safety could provide valuable guidance for optimizing perioperative analgesia in these patients.

This description comes directly from the study's public registry record.

Talk to the study team

sarah m elgamal, MD  ·  01005496440  ·  sarahelgamal1990@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Alexandria UniversityAlexandria, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07693621